Clinical Trials
25 trialsNCT07594327 2026-05-22
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Tampere University Hospital
Enrolling by invitation
NCT04169763 2026-05-20
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT03180294 2026-05-19
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
Phase 2 Completed
NCT02834013 2026-05-13
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05903833 2026-05-11
PIERCE
AGO Research GmbH
Phase 2 Recruiting
NCT05979610 2026-05-11
Reiki-Brachy
University of Utah
Phase 2 Recruiting
NCT04713618 2026-05-07
GEORGIA
Ohio State University Comprehensive Cancer Center
Active not recruiting
NCT05934851 2026-05-06
A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia
Wake Forest University Health Sciences
Phase NA Active not recruiting
NCT06023862 2026-05-06
DOVE
Yonsei University
Phase 2 Recruiting
NCT04430699 2026-05-05
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT07124000 2026-05-01
DP-04
AstraZeneca
Recruiting
NCT06495554 2026-04-29
DaVulvaRec
University of Aarhus
Phase NA Recruiting
NCT07407647 2026-04-21
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT06039111 2026-04-13
IGNITE-V
Hamilton Health Sciences Corporation
Recruiting
NCT04708470 2026-04-06
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Active not recruiting
NCT07290894 2026-04-02
MITO VULVA-01
National Cancer Institute, Naples
Phase 2 Recruiting
NCT04122235 2026-03-30
LETSGO
Sorlandet Hospital HF
Phase NA Completed
NCT06447064 2026-03-25
(CLOCS-2)
Imperial College London
Recruiting
NCT06476639 2026-03-24
ANVU
Queensland Centre for Gynaecological Cancer
Phase 3 Not yet recruiting
NCT06662435 2026-03-23
GYNCOG
Northwestern University
Phase NA Completed
NCT03987555 2026-03-18
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
Suspended
NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00791635 2026-03-05
Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer
M.D. Anderson Cancer Center
Active not recruiting